EUR 2.4
(-1.15%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 35.81 Million EUR | 3.05% |
2022 | 34.75 Million EUR | -29.63% |
2021 | 49.38 Million EUR | 95.33% |
2020 | 25.28 Million EUR | 56.84% |
2019 | 16.12 Million EUR | -11.17% |
2018 | 18.14 Million EUR | -46.85% |
2017 | 34.14 Million EUR | -26.66% |
2016 | 46.55 Million EUR | 38.76% |
2015 | 33.54 Million EUR | 87.74% |
2014 | 17.87 Million EUR | 4178.62% |
2013 | 417.65 Thousand EUR | -14.49% |
2012 | 488.4 Thousand EUR | -95.34% |
2011 | 10.47 Million EUR | 124.34% |
2010 | 4.66 Million EUR | -7.05% |
2009 | 5.02 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 32.8 Million EUR | 0.0% |
2023 Q2 | 22.55 Million EUR | 0.0% |
2023 FY | 35.81 Million EUR | 3.05% |
2023 Q4 | 35.81 Million EUR | 0.0% |
2022 FY | 34.75 Million EUR | -29.63% |
2022 Q2 | 43.86 Million EUR | 0.0% |
2022 Q4 | 34.75 Million EUR | 0.0% |
2021 Q2 | 47.21 Million EUR | 0.0% |
2021 Q4 | 49.38 Million EUR | 0.0% |
2021 FY | 49.38 Million EUR | 95.33% |
2020 Q4 | 25.28 Million EUR | 0.0% |
2020 FY | 25.28 Million EUR | 56.84% |
2020 Q2 | 29.15 Million EUR | 0.0% |
2019 Q4 | 16.12 Million EUR | 0.0% |
2019 Q2 | 15.89 Million EUR | 0.0% |
2019 FY | 16.12 Million EUR | -11.17% |
2018 FY | 18.14 Million EUR | -46.85% |
2018 Q4 | 18.14 Million EUR | 0.0% |
2018 Q2 | 24.64 Million EUR | 0.0% |
2017 Q2 | 40.39 Million EUR | 0.0% |
2017 FY | 34.14 Million EUR | -26.66% |
2017 Q4 | 34.14 Million EUR | 0.0% |
2016 FY | 46.55 Million EUR | 38.76% |
2016 Q4 | 46.55 Million EUR | 0.0% |
2016 Q2 | 31.14 Million EUR | 0.0% |
2015 Q4 | 33.54 Million EUR | 0.0% |
2015 Q2 | 16.09 Million EUR | 0.0% |
2015 FY | 33.54 Million EUR | 87.74% |
2014 Q4 | 17.87 Million EUR | 0.0% |
2014 FY | 17.87 Million EUR | 4178.62% |
2014 Q2 | 2.42 Million EUR | 0.0% |
2013 Q2 | 4.48 Million EUR | 0.0% |
2013 FY | 417.65 Thousand EUR | -14.49% |
2013 Q4 | 417.65 Thousand EUR | 0.0% |
2012 Q4 | 488.4 Thousand EUR | 0.0% |
2012 Q2 | 9.38 Million EUR | 0.0% |
2012 FY | 488.4 Thousand EUR | -95.34% |
2011 Q4 | 10.47 Million EUR | 0.0% |
2011 FY | 10.47 Million EUR | 124.34% |
2010 FY | 4.66 Million EUR | -7.05% |
2009 FY | 5.02 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Affluent Medical SA | 56.62 Million EUR | 36.754% |
Bluelinea Société Anonyme | 13.16 Million EUR | -172.03% |
Carmat SA | 53.06 Million EUR | 32.518% |
Diagnostic Medical Systems S.A. | 51.13 Million EUR | 29.97% |
Euromedis Groupe | 46.25 Million EUR | 22.583% |
Eurobio Scientific Société anonyme | 315.81 Million EUR | 88.66% |
Ikonisys S.A. | 20.85 Million EUR | -71.739% |
Implanet S.A. | 10.63 Million EUR | -236.674% |
SpineGuard SA | 11.03 Million EUR | -224.521% |
Theraclion SA | 18.66 Million EUR | -91.882% |
Euroapi S.A. | 1.61 Billion EUR | 97.779% |
Guerbet SA | 1.02 Billion EUR | 96.507% |